Author

V. Mariano

Observed names: V Mariano, Valentina Mariano

Observed institutions: University of Padua, Royal Devon & Exeter NHS Foundation Trust

OpenAlex ID: A5059833620

Optimized glycaemic control achieved with add‐on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine

2011 · G. P. Fadini, S. V. de Kreutzenberg, et al. · Diabetes Obesity and Metabolism · 53

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study

2016 · S. Galasso, A. Facchinetti, et al. · Nutrition Metabolism and Cardiovascular Diseases · 27

Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy

2017 · L. Indelicato, V. Mariano, et al. · Diabetic Medicine · 24

Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes

2019 · E. Cipponeri, N. Vitturi, et al. · Journal of Endocrinological Investigation · 18

Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care

2023 · Mario Luca Morieri, Riccardo Candido, et al. · Diabetes Therapy · 13

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 11

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 11

Citation count: 243

H-index: 9

I10-index: 9